| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
0.535 |
Evidence |
|
| APOL1 |
APOL1, APOL: Apolipoprotein-L1 precursor |
F5 |
F5: Coagulation factor V precursor |
0.535 |
Evidence |
|
| SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| AKAP4 |
AKAP4, AKAP82: A-kinase anchor protein 4 precursor |
PRKAR2B |
IPI00456775 |
0.535 |
Evidence |
|
| NFKB2 |
IPI00477537 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.535 |
Evidence |
|
| FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
O
|
| JAK1 |
|
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| IGHE |
IGHE: Ig epsilon chain C region |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| IGHG1 |
IPI00645627 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| IGHG1 |
IPI00645627 |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| IGHA2 |
IGHA2: Ig alpha-2 chain C region |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| IGHA2 |
IGHA2: Ig alpha-2 chain C region |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| IGHA2 |
IGHA2: Ig alpha-2 chain C region |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| IGHD |
IPI00549398 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| IGHD |
IPI00549398 |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| IGHD |
IPI00549398 |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| IGHD |
IPI00549398 |
IGHA2 |
IGHA2: Ig alpha-2 chain C region |
0.535 |
Evidence |
|
| TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
NFKB2 |
IPI00477537 |
0.535 |
Evidence |
|
| USP19 |
USP19, KIAA0891, ZMYND9: Ubiquitin carboxyl-terminal hydrolase 19 |
CRYBA4 |
CRYBA4: Beta-crystallin A4 |
0.535 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.535 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.535 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.535 |
Evidence |
|
| FLT4 |
VEGFR3 long form |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.535 |
Evidence |
|